Extracellular Gal-3 acts as a mediator that regulates metastatic cancer processes by recognizing N-acetyllactosamine (β-galactoside)-conjugated proteins, including EGFR, integrins, TGF-β receptors, etc. [25,27,28]. Here, LGALS3 is linked to cancer.